section name header

Pronunciation

am-pi-SIL-in

Classifications

Therapeutic Classification: anti-infectives

Pharmacologic Classification: aminopenicillins

Indications

REMS


Unlabeled Use:
  • Prevention of infection in certain high-risk patients undergoing cesarean section.

Action

  • Binds to bacterial cell wall, resulting in cell death.
Therapeutic effects:
  • Bactericidal action; spectrum is broader than penicillin.

Spectrum:

Pharmacokinetics

Absorption: Moderately absorbed from the duodenum (30–50%).

Distribution: Diffuses readily into body tissues and fluids. CSF penetration is in the presence of inflamed meninges. Crosses the placenta; enters breast milk in small amounts.

Metabolism/Excretion: Variably metabolized by the liver (12–50%). Renal excretion is variable (25–60% after oral dosing; 50–85% after IM administration).

Half-Life: Neonates: 1.7–4 hr; Children and Adults: 1–1.5 hr ( in renal impairment).

Time/Action Profile

(blood levels)

ROUTEONSETPEAKDURATION
POrapid1.5–2 hr4–6 hr
IMrapid1 hr4–6 hr
IVrapidend of infusion4–6 hr



Contraind./Precautions

Contraindicated in:

Use Cautiously in:

Adv. Reactions/Side Effects

Interactions

Drug-drug:

Route/Dosage

Respiratory and Soft-Tissue Infections

Bacterial Meningitis Caused by H. influenzae, Streptococcus pneumoniae, Group B streptococcus or N. meningitidis or Septicemia

GI/GU Infections other than N. gonorrhoeae

N. gonorrhoeae

Urethritis Caused by N. gonorrhoeae in Men

Prevention of Bacterial Endocarditis

Renal Impairment

Availability

(Generic available)

Assessment

Lab Test Considerations:

Implementation

IV Administration:

Patient/Family Teaching

Evaluation/Desired Outcomes

Code

NDC Code